Loading...
Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
OBJECTIVES: Plasma creatinine is a predictor of survival in amyotrophic lateral sclerosis (ALS). It remains, however, to be established whether it can monitor disease progression and serve as surrogate endpoint in clinical trials. METHODS: We used clinical trial data from three cohorts of clinical t...
Na minha lista:
| Udgivet i: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5800333/ https://ncbi.nlm.nih.gov/pubmed/29084868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2017-317077 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|